Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

DATA COMPILATION
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Protopic

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

73 API Suppliers, 31 USDMF, 12 CEP/COS, 7 JDMF, 8 EU WC, 15 KDMF, 26 NDC API, 33 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

162 Drugs in Development

162 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

827 FDF Dossiers, 63 FDA Orange Book, 538 Europe, 22 Canada, 96 Australia, 23 South Africa, 85 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 0.75MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 1MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 4MG BASE, CAPSULE;ORAL - EQ 0.5MG BASE, CAPSULE;ORAL - EQ 1MG BASE, CAPSULE;ORAL - EQ 5MG BASE

RELATED EXCIPIENT COMPANIES

2 SPI Pharma, 3 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Capital Farma, 1 Kirsch Pharma, 1 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 BASF, 11 Corel Pharma Chem, 4 DFE Pharma, 1 Finar, 4 Gangwal Chemicals, 3 Ideal Cures, 1 Ingredion Pharma Solutions, 22 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 1 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 3 Roquette, 7 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

39 Coating Systems & Additives, 19 Fillers, Diluents & Binders, 18 Granulation, 17 Direct Compression, 13 Lubricants & Glidants, 12 Controlled & Modified Release, 10 Film Formers & Plasticizers, 9 Empty Capsules, 9 Disintegrants & Superdisintegrants, 8 Solubilizers, 7 Emulsifying Agents, 7 Topical, 6 Thickeners and Stabilizers, 5 Taste Masking, 4 Co-Processed Excipients, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Parenteral, 2 Surfactant & Foaming Agents, 2 Coloring Agents, 2 Rheology Modifiers, 1 Chewable & Orodispersible Aids

DIGITAL CONTENT

71 News #PharmaBuzz

71 News #PharmaBuzz

GLOBAL SALES INFORMATION

25 US Medicaid Prescriptions, 76 Regulatory FDF Prices, 12 Annual Reports

MARKET PLACE

49 APIs, 14 FDF Dossiers

PATENTS & EXCLUSIVITIES

45 US Patents, 6 US Exclusivities, 29 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP, 1 JP, 7 Others

ANALYTICAL

1 BioAnalytical Methods, 4 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
27/02/2026	Chunghwa Chemical Synthesis & Biotech	Taiwan	Chunghwa Chemical Synthesis & Biotech Co., Ltd. Shu Lin TW	CEP 2018-241 - Rev 03	Tacrolimus monohydrate	2026-02-06	Valid	Chemical		2244
27/02/2026	Fishfa Biogenics	India	FISHFA BIOGENICS Rajkot IN	CEP 2023-394 - Rev 00	Tacrolimus monohydrate	2025-09-17	Valid	Chemical		2244

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Protopic

Protopic

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

73 API Suppliers

31 USDMF

12 CEP/COS

7 JDMF

8 EU WC

15 KDMF

26 NDC API

33 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

162 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

827 FDF Dossiers

63 FDA Orange Book

538 Europe

22 Canada

96 Australia

23 South Africa

85 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 0.75MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 1MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 4MG BASE

CAPSULE;ORAL - EQ 0.5MG BASE

CAPSULE;ORAL - EQ 1MG BASE

CAPSULE;ORAL - EQ 5MG BASE

RELATED EXCIPIENT COMPANIES

2 SPI Pharma

3 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

1 Capital Farma

1 Kirsch Pharma

1 Dr. Paul Lohmann GmbH & Co. KGaA

4 ACG Worldwide

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 BASF

11 Corel Pharma Chem

4 DFE Pharma

1 Finar

4 Gangwal Chemicals

3 Ideal Cures

1 Ingredion Pharma Solutions

22 Kerry

1 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

9 Microlex e.U

1 Nanjing Bold Chemical

1 Neelkanth MineChem

1 Nitika Pharmaceutical Specialities

1 Novo Excipients

4 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

3 Roquette

7 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

3 Sigachi Industries

2 Silverline Chemicals

2 The Dow Chemical Company

1 Valens Pharmachem

2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

39 Coating Systems & Additives

19 Fillers, Diluents & Binders

18 Granulation

17 Direct Compression

13 Lubricants & Glidants

12 Controlled & Modified Release

10 Film Formers & Plasticizers

9 Empty Capsules